Elites Getting Nervous About Their Deliberate Suppression Of Treatment Protocols

 covid19criticalcare | Science marches on!

We are a group of expert clinicians who are driven only by our desire to save lives.  We continually update our protocols based on clinical observations as well as the best studies of modes of prevention and treatment therapies for COVID-19.   For our latest, most comprehensive clinical guide to the management of COVID-19, please click the following text, or the box below the logos, to read and download  “An Overview of the MATH+, I-MASK+ and I-RECOVER Protocols, A Guide to the Management of COVID-19”, by Dr. Paul Marik.

Studies recently affecting our protocols:

• Ivermectin: a multifaceted drug of Nobel prize-honored distinction with indicated efficacy against a new global scourge, COVID-19
• Gender‐based disparities in COVID-19 patient outcomes
• Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomized, placebo-controlled, phase 2b/3 trial

In October of 2020, ivermectin was adopted as a core medication in our protocols for the prevention and treatment of COVID-19. For more information on ivermectin please go to our new Ivermectin in COVID-19 page. You can also read our review paper, which was published in the May 1, 2021, edition of the American Journal of Therapeutics as the “Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19”.

Ivermectin, an anti-parasitic medicine that is on the WHO’s list of essential medicines, has been given 3.7 billion times around the globe, and has won the Nobel prize in 2015 for its global and historic impacts in eradicating endemic parasitic infections in many parts of the world. Ivermectin has proven to be highly potent against COVID-19. It has shown antiviral and anti-inflammatory properties in observational and randomized controlled studies conducted throughout the world. Practitioners and Health Ministries who have adopted Ivermectin in treatment protocols report significant reductions in time to recovery, hospitalizations, and death. The use of Ivermectin as prophylaxis and prevention has also been proven in studies to reduce the spread of infection and offer protection to high-risk individuals.

Support for Ivermectin in the use of prophylaxis can be found here: https://scivisionpub.com/pdfs/ivermectin-as-prophylaxis-against-covid19-retrospective-cases-evaluati…